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Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are chronic diseases characterized by activation of the
immune system and production of antibodies. Thus, rheumatoid factor, anti-animal IgG antibodies and heterophilic
antibodies in plasma samples from arthritis patients can interfere with immunoassays such as sandwich enzyme-
linked immunosorbent assay (ELISA) systems often used in arthritis research. However, standard methodologies on
how to test for false results caused by these antibodies are lacking. The objective of this study was to design a
simple set of steps to validate a sandwich ELISA before using it for measuring analytes in plasma from arthritis
patients. An interleukin-24 (IL-24) sandwich ELISA system was prepared with a monoclonal mouse capture antibody
and a polyclonal goat detection antibody and tested for interference by rheumatoid factor, anti-animal IgG
antibodies and heterophilic antibodies. Plasma samples from 23 patients with RA and SpA were used. No
differences were found between plasma samples measured in wells coated with anti-IL-24 specific antibody and in
wells coated with isotype control antibody (false positive results), and recombinant human IL-24 was not recovered
in spiked samples (false negative results). This interference was removed after preincubating the plasma samples
from patients with arthritis with goat or bovine IgG, suggesting that anti-animal IgG antibodies found in the plasma
of the arthritis patients caused the false results. Additional testing showed that the signal-to-noise ratio could be
increased by titration of the capture and detection antibodies and by using the ELAST amplification system. Finally,
the calculated concentration of IL-24 was increased in ethylenediaminetetraacetic acid (EDTA) plasma compared to
heparin plasma and serum and decreased with repetitive freeze/thaw cycles of the samples illustrating how sample
handling could additionally contribute to the variations reported by different laboratories in measurement of the
same analyte. This study proposes a simple set of validation steps to evaluate and optimize a sandwich ELISA
before using it for measuring analytes in plasma from arthritis patients. Anti-animal IgG antibodies are also present
in healthy individuals, suggesting that validation of ELISA systems for measuring non-arthritis samples could also be
improved by this simple set of validation steps.
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Rheumatoid arthritis (RA) and spondyloarthritis (SpA)
are chronic inflammatory diseases characterized by dif-
fuse activation of leukocytes and production of anti-
bodies (Dougados and Baeten 2011; McInnes and Schett
2011). These antibodies are autoantibodies, anti-animal
protein antibodies and heterophilic antibodies (Bartels
and Ribel-Madsen 2013). Autoantibodies are antibodies
to immunological self-antigens, in the human body typ-
ically other proteins of an endogenous origin. Rheu-
matoid factor is an autoantibody against the fragment
crystallizable region (Fc region) of human IgG and is a
characteristic of RA but can also increase in healthy in-
dividuals during an infection (Ball and Lawrence 1961;
Waaler 1940; Welch et al. 1983). Several other autoanti-
bodies are found in both RA and SpA patients (Duskin
and Eisenberg 2010; Wright et al. 2012). Anti-animal
protein antibodies are antibodies to animal proteins, e.g.
animal IgG (Degn et al. 2011; Husby et al. 1985). These
antibodies are prevalent in plasma from patients with
both RA and SpA and in plasma from healthy individ-
uals. Human anti-animal IgG antibodies can arise from
multiple sources including blood transfusion, vaccin-
ation or transfer of dietary antigens across the gut wall
(Andersen et al. 2004; Hawkins et al. 1980; Jewell and
Truelove 1972). One study reported such antibodies to
be found in 95% of plasma samples collected from
healthy individuals (Andersen et al. 2004). Heterophilic
antibodies are weak and polyspecific antibodies. These
antibodies are found in healthy individuals as natural
antibodies inherently produced by the immune system
and are increased in autoimmune disease (Levinson and
Miller 2002).
Rheumatoid factor, anti-animal IgG antibodies and hete-
rophilic antibodies can be a major problem in immunoas-
says such as sandwich enzyme-linked immunosorbent
assay (ELISA) systems. In particular human rheumatoid
factor is notorious for its ability to bind the Fc region of
IgG from nearly any species (Hamilton et al. 1988). The
sandwich ELISA is usually performed by first immobilizing
a capture antibody in polystyrene wells, then adding the
sample containing the analyte and finally developing a re-
action with a detection antibody conjugated to an enzyme.
Usually these antibodies are monoclonal mouse or rat
antibodies or purified polyclonal antibodies from rabbits
or goats. False positive results can be caused if rheumatoid
factor, anti-animal IgG antibodies or heterophilic anti-
bodies bridge the capture and detection antibodies to yield
a signal even in the absence of analyte (Bartels et al. 2011;
Ismail et al. 2002; Levinson and Miller 2002; Selby 1999).
False negative results can be caused if these antibodies
react with either the capture antibody or the detection
antibody preventing reaction with the analyte (Kricka
1999). Anti-animal IgG antibodies are a problem, especiallywhen monoclonal antibodies are used in the sandwich
ELISA. Thus monoclonal antibodies made by hybridomas
cultured in medium with fetal calf serum (FCS) could be
contaminated with bovine IgG. This contamination occurs
because commercially available FCS contains bovine IgG
contaminating the hybridoma supernatant. Purification of
the IgG fraction of the hybridoma supernatant on a protein
A or G column is not species specific, and both monoclo-
nal antibody and bovine IgG are collected (Goudswaard
et al. 1978). The contaminating bovine IgG has been re-
ported to comprise up to 95% of the immunoglobulin in
the hybridoma supernatant (Harlow and Lane 1988). Hu-
man anti-bovine IgG antibodies in the sample to be mea-
sured can thus bridge contaminating bovine IgG in the
capture and detection mouse antibody solutions. Also anti-
bovine IgG antibodies often cross-react with especially goat
IgG due to species similarities. This can cause problems in
sandwich ELISA systems with a combination of monoclo-
nal mouse and polyclonal goat antibodies. There are sev-
eral other factors influencing the binding of capture and
detection antibodies to the analyte, e.g. presence of soluble
receptors (Engelberts et al. 1991).
Immunoassays are used both in the clinical setting and
for research. The problem with interfering rheumatoid
factor, anti-animal IgG antibodies and heterophilic anti-
bodies is generally accepted and different recommenda-
tions have been made to reduce false positive results.
Thus, interference can be diminished by preincubating
the samples with animal serum, animal immunoglobulin
or a commercially available blocking agent or by using
protein precipitation with either polyethylene glycol or
Protein A, G or L (Bartels and Ribel-Madsen 2013).
Interference in clinical diagnostic immunoassays may re-
sult in misdiagnosis and mistreatment (Sturgeon and
Viljoen 2011). Thus, diagnostic companies put a lot of
effort into preventing and controlling it. In the research
setting, recommendations on how to make a simple val-
idation of a sandwich ELISA for measuring plasma sam-
ples are still lacking. Thus, both commercially available
and in-house sandwich ELISA systems and multiplex
systems are frequently used with the risk of getting false
results (Churchman et al. 2012; de Jager et al. 2005;
DeForge et al. 2010; Martins et al. 2004; Todd et al. 2011).
Interleukin-24 (IL-24) is a member of the IL-10 family
of cytokines comprising IL-10, IL-19, IL-20, IL-22, IL-24,
IL-26, IL-28, and IL-29 sharing amino acid identity and
protein structure (Ouyang et al. 2011). Furthermore, IL-
19, IL-20 and IL-24 share the same two receptor com-
plexes of IL-20R1/IL-20R2 and IL-22R/IL-20R2. IL-24
is primarily believed to be a tumor suppressor but has
also been described in RA and SpA (Dash et al. 2010;
Kragstrup et al. 2008).
This study establishes a simple set of steps to validate
and optimize a sandwich ELISA before using it for
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IL-24 sandwich ELISA system as an example consisting
of a mouse capture antibody and a goat detection
antibody.
Results
Preparing the ELISA system
The sandwich ELISA used as an example in this study
was a sandwich ELISA directed against the cytokine IL-
24. The capture antibody was a protein A or G purified
mouse anti-IL-24 monoclonal IgG2a antibody and the
detection antibody was a goat anti-IL-24 polyclonal anti-
body. First, measuring the optical density (OD) signal
from blank wells with diluent after blocking the non-
specific binding sites in the polystyrene wells examined
the best blocking reagent. Phosphate buffered saline
(PBS) supplemented with 5% skimmed milk reduced the
background noise most efficiently (Figure 1A).
Then, the signal-to-noise ratio was optimized. Both cap-
ture and detection antibodies were titrated at three differ-
ent concentrations measuring blank assay diluent (noise)
and assay diluent with 1000 pg/ml of recombinant human

















































































































Figure 1 Preparing the sandwich ELISA system. (A) Testing different blo
wells with blank assay diluent after blocking the wells with different blockin
signal from wells with blank assay diluent (noise) and wells with 1000 pg/m
capture antibody and detection antibody. Numbers represent concentratio
and wells with 1000 pg/ml rh IL-24 in assay diluent (signal) without or with
three different arthritis patients without or with amplification.to be 2 μg/ml for the capture antibody and 0.8 μg/ml for
the detection antibody (Figure 1B). Furthermore, an amp-
lification step with biotinyl-tyramide was tested. This in-
creased the signal-to-noise ratio from 4.7 to 9.9 increasing
the sensitivity of the assay (Figures 1C and 1D).
Validating the ELISA system for measuring plasma from
arthritis patients by testing for false positive results, false
negative results and other matrix effects
Sandwich ELISA analysis of samples from RA and SpA
patients are often complicated by the presence of rheuma-
toid factor, anti-animal IgG antibodies or heterophilic anti-
bodies. First, an analysis to identify false positive results
caused by these factors was conducted. Thus, to identify
false positive results plasma samples from patients with
arthritis were both measured in wells coated with anti-IL-
24 specific antibody and in wells coated with isotype
matched control antibody in an identical concentration.
OD readings were similar in wells coated with isotype
antibody compared with wells coated with antigen specific
antibody indicating false positive results (Figure 2A). To
reduce the amount of unspecific binding, the plasma sam-
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l rh IL-24 in assay diluent (signal) using different concentrations of
ns in μg/ml. (C) OD signal from wells with blank assay diluent (noise)
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Figure 2 Testing for false positive results. (A) False positive measurements. OD signal from four patient samples in wells coated with anti-IL-24
specific antibody or with isotype control antibody. (B) Identification and removal of false positive measurements. OD signal from the same four
patient samples in wells coated with anti-IL-24 specific antibody or with isotype control antibody after preincubating samples with a combination
of mouse, goat, bovine and human immunoglobulins. (C) Identification of species specificity of the anti-animal IgG antibodies in the patient
samples. OD signal from the same four patient samples in wells coated with isotype antibody after preincubating samples with different
immunoglobulins as indicated.
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globulins. Preincubation with immunoglobulins lowered
the OD readings in wells coated with isotype antibody
without eliminating the true OD readings in wells
coated with antigen specific antibody (Figure 2B). To
further determine the origin of the interfering an-
tibodies, samples were incubated with either mouse
IgG, goat IgG, bovine IgG or human immunoglobulin.
There was a dramatic decrease in unspecific binding
after adding bovine IgG or goat IgG with much less ef-
fect of adding mouse IgG or human immunoglobulin
(Figure 2C) indicating that the antibodies interfering
with the assay were anti-animal IgG antibodies with re-
activity to goat and bovine IgG. Thus, false positive re-
sults were identified and reduced.
Then, possible inhibitors of the ELISA system produ-
cing false negative results were identified. Thus, the
samples were spiked with rh IL-24 before and after
preincubation with mouse, goat, bovine and human
immunoglobulins. Spiked samples with recombinant
cytokine only increased the OD readings in samples
preincubated with immunoglobulin indicating false
negative results (Figures 3A and 3B). Another three pa-
tient samples were spiked to an expected concentra-
tion of rh IL-24 of 800 pg/ml and recovery was
calculated to be 108%, 106% and 93% (Figure 3C).Finally, the sandwich ELISA was further tested for
other matrix effects by diluting plasma samples from
arthritis patients. The samples could be diluted 2-fold
showing almost linearity until reaching a concentration
of IL-24 of approximately 25 pg/ml (Figure 3D).
Testing the ELISA system for variability, stability of
analyte, effect of sample anticoagulant, effect of assay
buffer content on the standard curve and cross-reactivity
First, inter-assay variability was tested. A positive control
sample was run in duplicates in different plates. The posi-
tive control sample was prepared by pooling ethylene-
diaminetetraacetic acid (EDTA) plasma from four healthy
individuals identified to have non-detectable concentra-
tions of IL-24 and adding rh IL-24 for a final concentra-
tion of 200 pg/ml. The inter-assay coefficient of variability
was calculated to be 25% (Figure 4A).
Then the stability of the cytokine was examined. Dif-
ferent vials of the positive control plasma sample were
stored under different conditions or exposed to freeze/
thaw cycles. Repetitive freeze/thaw cycles resulted in
small decreases in measured concentrations of IL-24
(Figure 4B).
Then, the effect of the anticoagulant used for the sam-
ple preparation on the calculated concentration of IL-24





























































Figure 3 Testing for false negative results and other matrix effects. (A) False negative measurements. OD signal from unspiked and spiked
plasma samples from two arthritis patients in wells coated with anti-IL-24 specific antibody. (B) Identification and removal of false negative
measurements. OD signal from unspiked and spiked plasma samples from the same two arthritis patients in wells coated with anti-IL-24 specific
antibody after preincubating samples with a combination of mouse, goat, bovine and human immunoglobulins. (C) Spike recovery assessment in
three other arthritis patients. Calculated IL-24 concentrations from unspiked patient samples and patient samples spiked with 800 pg/ml rh IL-24
in wells coated with anti-IL-24 specific antibody after preincubating samples with immunoglobulins. (D) Linearity-of-dilution assessment in three
other arthritis patients. Calculated IL-24 concentrations in samples preincubated with immunoglobulin and diluted 4/6, 2/6 and 1/6 in wells
coated with anti-IL-24 specific antibody.
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The concentration of measured IL-24 was best detected
in plasma stabilized with EDTA (Figure 4C).
Adding high concentrations of immunoglobulin to the
assay diluent can potentially alter the signals in the stand-
ard curve. Thus, standard curves were prepared using
assay diluent with and without immunoglobulin. The
standard curve showed a small decrease in OD signal after
adding immunoglobulin to the assay diluent (Figure 4D).
IL-24 shares amino acid sequence, protein structure and
receptor subunits with IL-19 and IL-20. Therefore cross-
reactivity to these two cytokines was tested. No cross-
reactivity was detected (data not shown).Discussion
Sandwich ELISA systems are frequently used in arth-
ritis research. Rheumatoid factor, anti-animal IgG an-
tibodies and heterophilic antibodies are commonly
found in human plasma and increased in arthritis pa-
tients and can cause interference in sandwich ELISA
systems. Thus, validation of any sandwich ELISA planed
for arthritis research is important. This study demon-
strates false positive results in plasma from arthritis
patients caused by anti-animal IgG antibodies and the
interference was identified and removed by a simple set
of validation steps.An anti-IL-24 sandwich ELISA system was prepared
with a mouse monoclonal capture antibody and a goat
polyclonal detection antibody after titration of the anti-
bodies. It seems evident that an in-house sandwich
ELISA constructed by the researcher should be validated
thoroughly but the following set of validation steps
could easily be used in any commercially available sand-
wich ELISA. Thus, commercially available kits are not
always constructed with the appropriate blockers in the
assay diluent and often not optimized for measuring
arthritis samples. Also, this type of testing should be
considered using other immunoassays such as multiplex
systems (Churchman et al. 2012).
The signal-to-noise ratio was increased by an amplifi-
cation step. The ELAST amplification system is based on
the reporter deposition technology (Bobrow et al. 1989).
This technique could become an important tool to in-
crease the sensitivity in ELISA systems in research be-
cause cytokines and chemokines are often found in low
concentrations in the blood. The most efficient plate
blocker was skimmed milk. Skimmed milk is a well-
known blocker of plastic surfaces and is always a good
possible candidate for further empirical testing in the
particular sandwich ELISA system to be prepared (Vogt
et al. 1987).
The results of the ELISA system were validated by a
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Figure 4 Additional testing of the ELISA system. (A) Testing the ELISA system for variability. Calculated IL-24 concentrations in the positive
control sample analyzed in nine different experiments. (B) Testing the ELISA system for stability of the analyte. Calculated IL-24 concentrations in
the positive control sample after storage under different conditions or after a variable number of freeze/thaw cycles (f/t). (C) Testing the ELISA
system for effect of the sample anticoagulant used. Calculated IL-24 concentrations in eight paired plasma samples from patients with arthritis
stabilized with either EDTA or heparin or serum samples. (D) Testing the ELISA system for effect on the standard curve of adding
immunoglobulins to the assay diluent. OD signal from samples of rh IL-24 diluted in assay buffer without immunoglobulin and from samples of
rh IL-24 diluted in assay buffer with immunoglobulin.
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sults. The false positive results were most probably caused
by anti-bovine IgG antibodies found in the plasma of the
arthritis patients cross binding contaminating bovine IgG
in the monoclonal capture antibody solution and the poly-
clonal goat detection antibody. Thus, the unspecific bind-
ing to the capture isotype antibody was removed after
preincubating the samples with either goat IgG or bovine
IgG. Rheumatoid factor did not seem to be a problem in
this sandwich ELISA, because preincubating the samples
with human immunoglobulin did not decrease the unspe-
cific binding. Though, it cannot be excluded that these pa-
tients were all rheumatoid factor negative. Preincubating
the samples with mouse IgG also reduced the false positive
results to a minor extent. This suggests that heterophilic
antibodies with weak polyspecificity could also account for
some of the interference. The false negative results could
be a result of the anti-animal IgG antibody reacting with
either the capture antibody or the detection antibody and
preventing reaction with the analyte (Kricka 1999). Thus,
the spiked rhIL-24 was only recovered after preincubating
the samples with immunoglobulin. Also, the OD increasedin some of the measured samples after preincubating the
samples with immunoglobulin. After preincubating the
samples with immunoglobulin dilution of three different
plasma samples showed assay linearity indicating that the
signal actually comes from detection of the analyte in the
sandwich ELISA. Though, even after thorough optimi-
zation residual interference cannot be completely ex-
cluded. A final step would be to measure all samples both
in wells coated with antigen specific antibody and in wells
coated with isotype control antibody and calculate the dif-
ference (Gjelstrup et al. 2010).
The validation of any sandwich ELISA used in arthritis
research is important and could be done in a simple setup
as described in this study and summarized in Table 1. The
tests could be done with 3–6 patients using only approxi-
mately one microplate and only little patient material.
Reporting the results from such a validation would only
require limited space in the materials and methods sec-
tion. This study demonstrates false positive results in
plasma from arthritis patients caused by anti-animal IgG
antibodies and not rheumatoid factor. This suggests that
the proposed validation setup should also be considered
Table 1 A simple set of steps to validate a sandwich ELISA for research use
Potential problem Validation step
The essential steps
False positive measurements Measure samples in wells coated with antigen specific antibody and in wells coated with an isotype
antibody. Use samples before and after preincubation with immunoglobulins or another blocking agent.
False negative measurements Spike samples with a known concentration of analyte and calculate the recovery. Use spiked samples
before and after preincubation with immunoglobulins or another blocking agent.
Other matrix effects Measure serial dilutions of samples to test for linearity. Use samples before and after preincubation with
immunoglobulins or another blocking agent.
The extra steps
Low signal-to-noise ratio Test different solutions for blocking the non-specific binding sites in the polystyrene wells. Titrate the
antibodies. Test an amplification step.
High variability or dissimilarities
between laboratories
Use a positive control sample in every plate. Test the effect of repetitive freeze/thaw cycles. Test the effect
of different sample anticoagulants. Test different buffers for making the standard curve.
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arthritis samples.
After the simple validation, the ELISA system was
tested further for variability, stability of the analyte, ef-
fect of anticoagulant used in the sample preparation, ef-
fect on the standard curve of adding immunoglobulins
to the assay diluent and cross-reactivity. The inter-assay
coefficient of variability was calculated to be 25%. This is
a somewhat high coefficient of variation, which must be
considered when interpreting results from the ELISA
system. EDTA plasma was superior to heparin plasma
and serum when meassuring the concentration of IL-24
in arthritis blood samples. The reason for the limited de-
tection in heparin plasma and serum is not known.
However, the effect of sample anticoagulant on analyte
detection has been shown for other cytokines previously
(de Jager et al. 2009), and it illustrates the importance of
choosing the appropriate anti-coagulant.
Repetitive freeze/thaw cycles seemed to decrease the
concentration of recombinant human IL-24 in the posi-
tive control sample. In this system, it is thus important
to consider the use of samples that have not been frozen
and thawed repeatedly. In a sandwich ELISA the con-
centration of analyte in the measured samples are typic-
ally calculated from a standard curve. Thus, it is
important that the samples and the standard curve are
measured in a diluent with a similar matrix. In this
sandwich ELISA system the addition of immunoglobulin
to the assay diluent changed the standard curve slightly.
These findings all illustrate ways in which different la-
boratories might find different concentrations of the
same analyte.
The test for cross-reactivity was conducted because
IL-24 shares amino acid sequence, protein structure and
receptor subunits with IL-19 and IL-20. This could be
relevant in other studies with cytokines or other analytes
with overlapping structures or functions. All these extra
tests should also be considered when optimizing a sand-
wich ELISA system for arthritis research.Conclusions
In conclusion, this study establishes an IL-24 sandwich
ELISA system and validates it for measuring plasma
from arthritis patients with a simple set of validation
steps. Any sandwich ELISA to be used in arthritis re-




Blood samples from 23 patients with chronic RA or SpA
with no registration apart from their diagnosis were
used. From 8 of the patients paired plasma samples sta-
bilized with either EDTA or heparin and serum samples
were analyzed. From the remaining of the patients either
plasma samples stabilized with EDTA or heparin were
used. To test for false positive results samples from 4
different patients were used and to test for false negative
results samples from 2 different patients were used. All
RA patients were diagnosed in accordance with the
American College of Rheumatology (ACR) 1987 classifi-
cation criteria (Arnett et al. 1988). All SpA patients met
the European Spondyloarthropathy Study Group (ESSG)
criteria (Dougados et al. 1991). EDTA plasma samples
were also collected from 4 healthy individuals to make a
positive control sample. These plasma samples were all
identified to have non-detectable concentrations of IL-
24. They were pooled and rh IL-24 was added for a final
concentration of 200 pg/ml. All samples were obtained
after informed written consent according to the Declar-
ation of Helsinki and approved by the Local Ethics Com-
mittee (project number 20050046).
Antibodies and reagents
A protein A or G purified anti-IL-24 monoclonal mouse
IgG2a antibody (clone number 283161, catalog number
MAB19652, RnD Systems, Minneapolis, USA) was used
as capture antibody and a biotin conjugated anti-IL-24
polyclonal goat antibody (catalog number BAF1965,
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ish peroxidase (HRP) conjugated streptavidin (catalog
number DY998, RnD Systems) was used for visualization
of bound antibody and rh IL-24 (from catalog number
DY1965, RnD systems) was used for creation of a stand-
ard curve for quantification of concentrations. Rh IL-19
(from catalog number DY1035, RnD Systems) and rh IL-
20 (from catalog number DY1102, RnD Systems) were
used to test for cross-reactivity to these cytokines. Unspe-
cific binding was assessed using a mouse IgG2a isotype
capture antibody (catalog number MAB003, RnD sys-
tems). Mouse, goat and bovine IgG for blocking potential
anti-animal IgG antibodies in the samples to be measured
were purchased from Jackson ImmunoResearch (catalog
numbers 015-000-003, 005-000-003 and 001-000-003,
West Grove, USA) and human immunoglobulin for
blocking potential anti-human immunoglobulin antibodies
in the samples to be measured were purchased from
Behring (Beriglobulin, King of Prussia, USA). Buffers to
block non-specific binding sites in polystyrene wells were
prepared with PBS pH 7.4, bovine serum albumin (BSA)
(catalog number 12659, Calbiochem, San Diego, USA),
normal goat serum (NGS) (catalog number 31873,
Thermo Scientific, Waltham, USA), FCS (catalog number
10270, Gibco, Life Technologies, Carlsbad, USA), HSA
(Human-Albumin 20%, 05002–00002, Behring), Super-
block PBS Blocking Buffer (product number 37515,
Thermo Scientific) and Protein Free PBS Blocking Buffer
(catalog number 37572, Thermo Scientific). Wash buffer
was prepared with PBS pH 7.4 with 0.05% Tween-20. For
amplification of the signal the ELAST ELISA Amplifica-
tion System was used (catalog number NEP116001EA,
PerkinElmer, Waltham, USA).
Assay diluent
The assay diluent was prepared as Protein-free PBS
Blocking Buffer with different combinations of 10 μg/ml
mouse IgG, 10 μg/ml goat IgG, 10 μg/ml bovine IgG
and 10 μg/ml human immunoglobulin (heat-aggregated
at 63°C for 30 min). Samples, positive control and stan-
dards were preincubated in assay diluent for 30 min at
room temperature (RT) before addition to the plate.
Samples and positive controls were diluted 2/3 in assay
diluent. Samples, positive controls and standards pre-
pared in assay diluent were added in a volume of 100 μl
and plates were incubated overnight at 4°C.
Blocking non-specific binding sites in polystyrene wells
The best blocking agent was determined in wells with
blank assay diluent by blocking the plate with 300 μl
of blocking buffer and incubating at RT for 2 hours.
The following blocking buffers were tested. PBS with
1% BSA, PBS with 1% BSA and 10% FCS, PBS with
1% BSA and 1% NGS, PBS with 1% BSA and 1%HSA, Superblock PBS Blocking Buffer, Superblock PBS
Blocking Buffer with 1% BSA, Superblock PBS Blocking
Buffer with 1% NGS, Protein-free PBS Blocking Buffer,
Protein-free PBS Blocking Buffer with 1% BSA, Protein-
free PBS Blocking Buffer with 1% NGS or PBS with 5%
skimmed milk. The optimal blocking buffer was found
to be PBS with 5% skimmed milk and this blocking
buffer was used in the subsequent experiments.Wash
Preceding all steps each well was washed three times
with PBS with 0.05% Tween-20.Capture and detection antibodies and streptavidin-HRP
For capture of analyte maxisorp microplates (Nunc,
Roskilde, Denmark) were coated with 100 μl per well of
capture antibody or isotype antibody and incubated
overnight at RT. The capture antibody concentration
was titrated using 2 μg/ml, 4 μg/ml and 8 μg/ml in PBS.
The optimal concentration was found to be 2 μg/ml and
for the subsequent experiments capture antibody or
isotype antibody were used in this concentration. For
detection of analyte 100 μl of biotinylated detection
antibody was added to each well and plates were incu-
bated 1 hour at RT. The detection antibody concentra-
tion was titrated using 0.4 μg/ml, 0.8 μg/ml and 1.6 μg/
ml in Protein-free PBS Blocking Buffer. The optimal
concentration was found to be 0.8 μg/ml and for the
subsequent experiments detection antibody was used in
this concentration. For enzyme delivery 100 μl of
streptavidin-HRP diluted 1/200 was added to each well
for 15 min at RT.Amplification and optical density measurement
For the amplification step plates were first incubated
with 100 μl of the biotinyl-tyramide solution per well for
15 min at RT and then for 30 min at RT with 100 μl
streptavidin-HRP diluted 1/1000. The amplification step
was used for all subsequent experiments. The plates
were then incubated with 100 μl of tetramethylbenzidine
(TMB) one (Kementec diagnostics, Taastrup, Denmark)
per well at RT. Color development was stopped with 50
μl of 1 M H2SO4 per well. The optical density of each
well was measured using a microplate reader set to 450
nm and wavelength correction set to 630 nm.Spike recovery and cross-reactivity
Samples were tested for spike recovery by adding rh IL-
24 to plasma samples from patients with arthritis. The
prepared IL-24 sandwich ELISA system was tested for
cross-reactivity to IL-19 and IL-20 by adding rh IL-19
and rh IL-20 to assay diluent.
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Results are reported as either OD signals or concentra-
tions calculated from a standard curve using rh IL-24.
The coefficient of variation was calculated as the stand-
ard deviation of the positive control (SD) divided by the
mean of the positive control (mean) multiplied by 100%
with the same positive control sample measured in nine
different experiments.
Coefficient of variation ¼ SD=mean  100%
The recovery of spiked rh IL-24 was calculated as the ob-
served concentration of spiked sample (observed spiked)
minus the observed concentration of the unspiked sample
(observed unspiked) divided by the expected concentration
of the spiked sample (expected spiked) multiplied by 100%.
Recovery ¼ Observed spiked−Observed unspikedð Þ=
Expected spiked  100%
Graphs were made with GraphPad Prism version 5
(GraphPad Software, San Diego, CA).
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